XIENCE™ V Everolimus Eluting Coronary Stent System India Post-Marketing Registry - Related Studies

XIENCE™ V Everolimus Eluting Coronary Stent System India Post-Marketing Registry (XIENCE V India)

This study is currently recruiting participants.

Study NCT00631228. Last updated on November 5, 2008. Information provided by Abbott Vascular

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Coronary Disease
		Coronary Artery Disease
		Coronary Restenosis

2	More general conditions related to this trial
		Arterial Occlusive Diseases
		Arteriosclerosis
		Cardiovascular Diseases
		Coronary Stenosis
		Heart Diseases
		Myocardial Ischemia
		Vascular Diseases

3	Additional drug interventions recognized in this trial
		Everolimus

4	More general drug interventions related to this trial
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		Abbott Vascular